Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.610
+0.020 (1.26%)
At close: Jun 26, 2026, 4:00 PM EDT
1.630
+0.020 (1.24%)
After-hours: Jun 26, 2026, 7:45 PM EDT
Autolus Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Autolus Therapeutics stock have an average target of 8.60, with a low estimate of 5.00 and a high estimate of 10. The average target predicts an increase of 434.16% from the current stock price of 1.61.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Autolus Therapeutics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 10 | 10 | 10 | 9 | 9 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 11 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $10 | Buy | Maintains | $10 | +521.12% | Jun 10, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 3, 2026 |
Unknown Analyst Wells Fargo No rating | Wells Fargo | Buy Reiterates $5 | Buy | Reiterates | $5 | +210.56% | May 15, 2026 |
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Buy Reiterates $6.1 → $5.4 | Buy | Reiterates | $6.1 → $5.4 | +235.40% | May 15, 2026 |
| Needham | Needham | Buy Maintains $10 | Buy | Maintains | $10 | +521.12% | May 14, 2026 |
Financial Forecast
Revenue This Year
129.15M
from 75.39M
Increased by 71.32%
Revenue Next Year
193.40M
from 129.15M
Increased by 49.74%
EPS This Year
-0.90
from -1.08
EPS Next Year
-0.63
from -0.90
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 146.5M | 225.0M | |
| Avg | 129.2M | 193.4M | |
| Low | 121.7M | 150.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 94.3% | 74.2% | |
| Avg | 71.3% | 49.7% | |
| Low | 61.4% | 16.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.56 | -0.42 | |
| Avg | -0.90 | -0.63 | |
| Low | -1.24 | -0.97 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.